Emergency Department Management of Uncomplicated Hyperglycemia in Patients without History of Diabetes

被引:1
作者
Schwartz, Xavier [1 ]
Porter, Blake [2 ]
Gilbert, Matthew P. [3 ]
Sullivan, Alison [4 ]
Long, Brit [5 ]
Lentz, Skyler [4 ,6 ]
机构
[1] Univ Vermont Med Ctr, Dept Emergency Med, Burlington, VT USA
[2] Univ Vermont Med Ctr, Dept Pharm, Burlington, VT USA
[3] Univ Vermont, Div Endocrinol & Diabet, Larner Coll Med, Burlington, VT USA
[4] Univ Vermont, Dept Emergency Med, Larner Coll Med, Burlington, VT USA
[5] Brooke Army Med Ctr, San Antonio Uniformed Serv, Emergency Med, Hlth Educ Consortium, San Antonio, TX USA
[6] Univ Vermont, Dept Emergency Med, Larner Coll Med, 111 Colchester Ave, Burlington, VT 05401 USA
关键词
hyperglycemia; diabetes; new onset dia-; breath; fever; glucocorticoid use; abdominal pain; nausea; IMPAIRED GLUCOSE-TOLERANCE; RANDOM PLASMA-GLUCOSE; TO-TARGET TRIAL; GLYCEMIC CONTROL; BLOOD-GLUCOSE; NPH INSULIN; TYPE-1; DIAGNOSIS; RISK; HYPOGLYCEMIA;
D O I
10.1016/j.jemermed.2023.04.018
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Hyperglycemia is a common finding in patients presenting to the emergency department (ED). Recommendations addressing uncomplicated hyperglycemia in the ED are limited, and the management of those without a prior diagnosis of diabetes presents a challenge. Objective: This narrative review will discuss the ED evaluation and management of hyperglycemic adult patients without a history of diabetes who do not have evidence of a hyperglycemic crisis, such as diabetic ketoacidosis or hywho present to the ED have risk factors for diabetes and meet American Diabetes Association (ADA) criteria for diabetes screening. A new diagnosis of type 2 diabetes can be established in the ED by the ADA criteria in patients with a random plasma glucose > 200 mg/dL (11.1 mmol/L) and symptoms of hyperglycemia. The diagnosis should be considered in patients with an elevation in random blood glucose > 140 mg/dL (7.8 mmol/L). Treatment may begin in the ED and varies depending on the presenting severity of hyper
引用
收藏
页码:e81 / e92
页数:12
相关论文
共 69 条
[1]   Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United States [J].
Aggarwal, Rahul ;
Vaduganathan, Muthiah ;
Chiu, Nicholas ;
Bhatt, Deepak L. .
CIRCULATION-HEART FAILURE, 2022, 15 (03)
[4]   Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S14-S80
[5]  
[Anonymous], 2018, GLUCOPHAGE (metformin hydrochloride) [package insert]. In
[6]  
[Anonymous], 2022, Jardiance (empagliflozin) Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease
[7]  
[Anonymous], Insulin pen injections
[8]  
[Anonymous], National Diabetes Statistics Report
[9]   A randomized, controlled trial of oral versus intravenous fluids for lowering blood glucose in emergency department patients with hyperglycemia [J].
Arora, Sanjay ;
Probst, Marc A. ;
Andrews, Laura ;
Camilion, Marissa ;
Grock, Andrew ;
Hayward, Gregory ;
Menchine, Michael .
CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2014, 16 (03) :214-219
[10]   SAFE AND SIMPLE EMERGENCY DEPARTMENT DISCHARGE THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS AND SEVERE HYPERGLYCEMIA [J].
Babu, Ambika ;
Mehta, Avinder ;
Guerrero, Pilar ;
Chen, Zhen ;
Meyer, Peter M. ;
Koh, Chung Kay ;
Roberts, Rebecca ;
Schaider, Jeffrey ;
Fogelfeld, Leon .
ENDOCRINE PRACTICE, 2009, 15 (07) :696-704